Acute promyelocytic leukemia is a distinct subset of acute myeloid leukemia with
characteristic clinical, morphological and genetic features. The gene product PML-RAR …

Acute promyelocytic leukemia (APL) is distinguished from other types of acute myeloid
leukemia by particular morphologic features. Management and prognosis of APL is …

It is important to detect PML/RARa rearrangement in patient with morphologic acute
promyelocytic leukemia (APL). Rare cases of APL lacking the classic t (15; 17) on routine …

We report the case of a patient with acute promyelocytic leukemia (APL) carrying a novel
chromosomal abnormality, t (2; 7)(q33; q36). The 54-year-old woman was morphologically …

Acute myeloid leukemia (AML) with t (8; 16)(p11; q13) is a distinct clinical and morphological
entity with poor prognosis, which is characterized by a high frequency of extramedullary …

Acute promyelocytic leukemia (APML) is cytogenetically characterized by t (15; 17)(q22;
q21), which results in the fusion of PML gene at 15q22 with the retinoic acid α-receptor …

Acute promyelocytic leukemia (APL) is characterized by the t (15; 17)(q22; q21), which
results in the fusion of the promyelocytic leukemia (PML) gene at 15q22 with the retinoic …

Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leukemia,
characterized by an accumulation of abnormal promyelocytes in the bone marrow, a severe …

Acute promyelocytic leukemia (APL) is characterized by the translocation t (15; 17)(q22;
q21). At diagnosis, 30–35% of patients shows additional cytogenetic changes. The influence …

Acute myeloid leukemia (AML-M3) is associated with the translocation t (15; 17)(q22; q12-
21) which disrupts the retinoic acid receptor alpha (RARA) gene on chromosome 17 and the …